Why Your First Month on Wegovy Matters Most
Understanding Wegovy's Essential 0.25mg Starting Phase
The Wegovy starter dose of 0.25mg during weeks 1-4 isn't arbitrary—it's a clinically proven approach to minimise side effects while allowing your body to adjust to this GLP-1 receptor agonist. Unlike other weight management approaches, Wegovy requires this specific dose escalation schedule, and skipping directly to higher doses can result in significant gastrointestinal side effects. Your 0.25mg pen contains four weekly doses, providing exactly one month of treatment to establish tolerance. This careful introduction allows the semaglutide to begin working on your brain's appetite centres while your digestive system adapts gradually.
Many patients notice subtle appetite changes during their starter phase, often describing feeling satisfied with smaller portions or experiencing reduced food cravings between meals. The 0.25mg dose may seem low compared to the maintenance 2.4mg, but it's therapeutically designed to begin the neurological changes that support long-term weight management. At EverydayMeds, our prescribers review your starter dose response to ensure you're ready for progression to 0.5mg in week five. This prescription-only medicine requires careful monitoring, which is why we provide ongoing clinical support throughout your escalation journey.
Wegovy Starter Pricing and Smart Bundle Options
Your Wegovy 0.25mg starter pen costs £79.99 with new customer code FIRST40 applied at checkout, representing exceptional value for this NHS-approved weight management treatment. For forward-thinking patients, our Intro Duo bundle provides both 0.25mg and 0.5mg pens for £169.99, covering your first eight weeks without additional orders. This bundle approach ensures treatment continuity and eliminates the stress of reordering during your crucial early weeks. Returning customers benefit from code DOSE25 for the same competitive pricing across all Wegovy doses.
Planning your first three months becomes even more convenient with our Intro Trio bundle, including 0.25mg, 0.5mg, and 1mg pens for £299.99. This comprehensive approach removes the uncertainty of individual ordering while guaranteeing your supply through week twelve. Our GPhC-registered pharmacy (#9012878) maintains competitive pricing without compromising on clinical quality or cold-chain storage requirements. Every bundle includes the same next-day delivery and clinical support as individual pen purchases, making your Wegovy journey as smooth as possible.
Clinical Evidence Supporting Wegovy's Dose Escalation
The STEP clinical trial programme, published by Wilding et al. in the New England Journal of Medicine (2021), established the safety and efficacy of Wegovy's specific dose escalation protocol. In STEP 1, patients following the 16-week escalation schedule experienced an average weight loss of approximately 15% at 68 weeks when taking Wegovy alongside diet and exercise. The starter dose phase proved crucial for treatment adherence, with patients who completed the full escalation showing significantly better long-term outcomes.
STEP 3 demonstrated that patients beginning with 0.25mg and following the prescribed escalation achieved approximately 16% average weight loss when combined with intensive behavioural therapy. The cardiovascular benefits revealed in the SELECT trial showed a 20% reduction in major cardiovascular events, highlighting Wegovy's impact beyond weight management. These results emphasise why the starter dose cannot be skipped—the gradual introduction allows patients to achieve therapeutic benefits while maintaining treatment tolerance.
How Wegovy's Mechanism Develops from Your First Dose
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for blood sugar regulation and appetite control. From your very first 0.25mg injection, Wegovy begins interacting with GLP-1 receptors in your brain's hypothalamus, gradually reducing appetite signals and enhancing satiety after meals. This mechanism develops progressively, which is why the starter dose might produce subtle effects that strengthen as you escalate through higher doses. The weekly injection schedule maintains consistent semaglutide levels, allowing these neurological changes to establish and intensify over your 16-week escalation period. Unlike stimulant-based appetite suppressants, Wegovy works with your body's existing hunger and fullness mechanisms rather than artificially suppressing them.
Streamlined Ordering Process for Your Starter Dose
Beginning Wegovy through EverydayMeds requires just a three-minute online clinical assessment covering your weight management history, current medications, and treatment goals. Our qualified prescribers review your assessment within three working days (or 24 hours with express service) to ensure Wegovy suits your individual circumstances. Once approved, your 0.25mg starter pen ships via next-day delivery using specialised cold-chain packaging that maintains the required 2-8°C temperature throughout transit. Our pharmacy team coordinates your delivery to ensure someone's available to receive this prescription-only medicine safely. You'll receive SMS tracking updates and injection guidance materials to support your first Wegovy experience.
Wegovy Storage and Practical Starter Dose Guidance
Your Wegovy 0.25mg pen arrives in temperature-controlled packaging and must be refrigerated at 2-8°C until use, though it can safely remain at room temperature below 30°C for up to six weeks once removed from the fridge. Each FlexTouch pen contains four weekly doses with clear dose markers and an intuitive injection mechanism suitable for self-administration. Store your pen in its original carton to protect from light, and never freeze or shake the medication. The weekly injection should ideally occur on the same day each week, with flexibility of plus or minus one day if needed. Rotate injection sites between your thigh, upper arm, or abdomen to prevent tissue irritation, and never inject into areas that are tender, bruised, or hard.
First Month Expectations and Side Effect Management
During your starter dose phase, most patients experience mild to moderate gastrointestinal effects including nausea, reduced appetite, and occasional stomach discomfort as your body adjusts to Wegovy's mechanism. These effects typically peak during weeks 2-3 before gradually subsiding as tolerance develops. Starting with smaller meals, eating slowly, and avoiding high-fat foods can significantly reduce nausea severity during this adaptation period. Many patients find their food preferences naturally shift toward lighter, more nutritious options as Wegovy begins influencing appetite signals.
Weight loss during the 0.25mg phase varies considerably, with some patients noticing immediate appetite changes while others experience gradual shifts in eating patterns. This variation is completely normal and doesn't predict your eventual treatment success at maintenance doses. Our clinical team provides ongoing support throughout your starter phase, helping you distinguish between normal adjustment effects and any concerning symptoms requiring medical attention. Remember that Wegovy works alongside dietary changes and increased physical activity, so establishing these lifestyle foundations during your starter month enhances long-term outcomes.
Planning Your Complete Wegovy Treatment Journey
Your 0.25mg starter dose represents just the beginning of a comprehensive 16-week dose escalation leading to the 2.4mg maintenance dose where Wegovy delivers its full therapeutic potential. Week five begins your progression to 0.5mg, followed by 1mg at week nine, 1.7mg at week thirteen, and finally 2.4mg from week seventeen onward. Each escalation step allows your body to adapt while building toward optimal appetite control and weight management benefits. Planning ahead with our bundle options ensures seamless progression without treatment interruptions that could compromise your results.
The newly approved 7.2mg dose (available from January 2026 but not yet stocked at EverydayMeds) offers additional options for patients requiring enhanced therapeutic effects after establishing tolerance at 2.4mg. Our clinical team monitors your progress throughout escalation, adjusting timing if you experience persistent side effects or require additional adaptation periods. This personalised approach ensures you achieve Wegovy's maximum benefits while maintaining comfort and treatment adherence throughout your weight management journey.
Ready to begin your Wegovy journey with confidence? Order your 0.25mg starter dose for £79.99 using code FIRST40, or secure your first two months with our Intro Duo bundle for £169.99. Our GPhC-registered pharmacy provides expert clinical support, next-day delivery, and ongoing guidance throughout your treatment. Visit our Wegovy starter dose page to complete your assessment and begin transforming your relationship with food. Your weight management success starts with that crucial first injection.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
